ES2134878T3 - SUBSTITUTED BENZOILGUANIDINES, PROCEDURE FOR ITS PREPARATION, ITS USE AS A MEDICATION OR DIAGNOSTIC AGENT, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM. - Google Patents
SUBSTITUTED BENZOILGUANIDINES, PROCEDURE FOR ITS PREPARATION, ITS USE AS A MEDICATION OR DIAGNOSTIC AGENT, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM.Info
- Publication number
- ES2134878T3 ES2134878T3 ES94108280T ES94108280T ES2134878T3 ES 2134878 T3 ES2134878 T3 ES 2134878T3 ES 94108280 T ES94108280 T ES 94108280T ES 94108280 T ES94108280 T ES 94108280T ES 2134878 T3 ES2134878 T3 ES 2134878T3
- Authority
- ES
- Spain
- Prior art keywords
- perfluoro
- cycloalkyl
- phenyl
- alkyl
- biphenylyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Abstract
There are described benzoylguanidines of the formula I <IMAGE> in which: R(1) is R(6)-CO or R(7)R(8)N-CO, where R(6), R(7) and R(8) are (perfluoro)alk(en)yl, -(CH)2n-R(9), R(9) is cycloalkyl, phenyl, biphenylyl or naphthyl, where R(7) and R(8) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; R(2) is defined as R(1), or is H, Hal, CN, NO2, (perfluoro)alk(en)yl, -(CH)2 R(15) where R(15) is cycloalkyl, phenyl, biphenylyl or naphthyl, or R(2) is (C1-C9)-heteroaryl, or R(2) is SR(18), -OR(18), -NR(18)R(19), -CR(18)R(19)R(20); R(18) = -(CH2)-heteroaryl, R(19), R(20) are defined as R(18) or are H, (perfluoro)-alkyl, or R(2) is R(21)-SOm or R(22)R(23)N-SO2-, where R(21) is (perfluoro)alk(en)yl, -CH2-R(24), R(24) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(22) is H, (perfluoro)alk(en)yl, -(CH2)n-R(29), R(29) is (C3-C8)-cycloalkyl, phenyl, biphenylyl or naphthyl, R(23) is H, (perfluoro)alkyl, where R(22) and R(23) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; or R(33)X-, where R(2) is X is oxygen, S, NR(34), (D=O)A-, NR(34)C=MN<(*)>R(35)-, where M is oxygen, S, A = oxygen, NR(34), D = C, SO R(33) and R(35) are (perfluoro)alk(en)yl, -(CH2)n-R(36), where R(36) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(34) = H, (perfluoro)alkyl, where A and N<(*)> are bonded to the phenyl ring of the benzoylguanidine parent structure; or R(2) is -SR(40), -OR(40), -NHR(40)R(41), -CHR(40)R(42), <IMAGE> -C=CR(45) <IMAGE> where R(40), R(41) are identical or different, and are -(CH2)p-(CHOH)q-(CH2)r-(CHOH)t-R(51) or -(CH2)p-O-(CH2-CH2O)q-R(51), R(51) is hydrogen or methyl, R(42), R(43) are hydrogen or alkyl or, together with the carbon atom carrying them, form a (C3-C8)-cycloalkyl; R(44) is H, (C1-C6)-alkyl, (C3-C8)-cycloalkyl, -CeH2e-R(45) where R(45) is phenyl, heteroaryl or alkyl, R(46), R(47), R(48), R(49) and R(50) are hydrogen or methyl; or R(2) is R(55)-NH-SO2-, R(3), R(4) and R(5) are independently of one another defined as R(1) or R(2); and their pharmaceutically tolerable salts.0
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4318756A DE4318756A1 (en) | 1993-06-05 | 1993-06-05 | Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them |
US08/459,966 US5679712A (en) | 1993-06-05 | 1995-06-02 | Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical or diagnostic, and pharmaceutical containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2134878T3 true ES2134878T3 (en) | 1999-10-16 |
Family
ID=25926534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94108280T Expired - Lifetime ES2134878T3 (en) | 1993-06-05 | 1994-05-30 | SUBSTITUTED BENZOILGUANIDINES, PROCEDURE FOR ITS PREPARATION, ITS USE AS A MEDICATION OR DIAGNOSTIC AGENT, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM. |
Country Status (17)
Country | Link |
---|---|
US (2) | US5679712A (en) |
EP (1) | EP0628543B1 (en) |
JP (1) | JP3563106B2 (en) |
CN (1) | CN1068308C (en) |
AT (1) | ATE181322T1 (en) |
AU (1) | AU674744B2 (en) |
CA (1) | CA2125104C (en) |
DE (2) | DE4318756A1 (en) |
DK (1) | DK0628543T3 (en) |
ES (1) | ES2134878T3 (en) |
FI (1) | FI942599A (en) |
GR (1) | GR3031111T3 (en) |
HU (1) | HU219452B (en) |
IL (1) | IL109887A (en) |
NO (1) | NO302361B1 (en) |
NZ (1) | NZ260681A (en) |
ZA (1) | ZA943895B (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59403818D1 (en) * | 1993-02-20 | 1997-10-02 | Hoechst Ag | Substituted benzoylguanidines, processes for their preparation, their use as medicaments, as inhibitors of cellular Na + / H + exchange or as diagnostic agents and medicaments containing them |
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4318658A1 (en) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them |
DE4318756A1 (en) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them |
DE4421536A1 (en) * | 1994-06-20 | 1995-12-21 | Hoechst Ag | Phenyl-substituted alkenylcarboxylic acid guanidines bearing perfluoroalkyl groups, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them |
IL114670A0 (en) * | 1994-08-05 | 1995-11-27 | Fujisawa Pharmaceutical Co | Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4430213A1 (en) * | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Arylbenzoylguanidine |
DE4441880A1 (en) * | 1994-11-24 | 1996-05-30 | Hoechst Ag | Substituted benzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
DE19502895A1 (en) * | 1995-01-31 | 1996-08-01 | Merck Patent Gmbh | 4-mercapto-benzoylguanidine derivatives |
DE19517848A1 (en) * | 1995-05-16 | 1996-11-21 | Merck Patent Gmbh | Fluorine-containing benzoylguanidines |
DE19531138A1 (en) * | 1995-08-24 | 1997-02-27 | Merck Patent Gmbh | Alkenyl benzoylguanidine derivatives |
EP0765867A1 (en) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
EP0765868A1 (en) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituted bezoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
DE19540995A1 (en) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituted sulfonimidamides, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
DE19542306A1 (en) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (en) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituted chromanylsulfonyl (thio) ureas, process for their preparation and their use in the manufacture of pharmaceutical preparations |
CA2195697A1 (en) | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
DE19608162A1 (en) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
DE19608161A1 (en) | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
DE19621319A1 (en) * | 1996-05-28 | 1997-12-04 | Hoechst Ag | Bis-ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and medicament containing them |
DE19622370A1 (en) * | 1996-06-04 | 1997-12-11 | Hoechst Ag | Ortho-substituted benzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
DE19624178A1 (en) * | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ortho-substituted benzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
DE19737463A1 (en) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Use of inhibitors of the sodium-hydrogen exchanger for the manufacture of a medicament for the treatment of diseases caused by protozoa |
IL126276A0 (en) * | 1997-09-24 | 1999-05-09 | Hoechst Marion Roussel De Gmbh | The use of an inhibitor of the na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system |
US6410563B1 (en) | 1999-12-22 | 2002-06-25 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
MY123585A (en) | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
US6639077B2 (en) | 2000-03-23 | 2003-10-28 | Merck Frosst Canada & Co. | Tri-aryl-substituted-ethane PDE4 inhibitors |
JP2003534328A (en) | 2000-05-25 | 2003-11-18 | メルク フロスト カナダ アンド カンパニー | Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitors |
US6740666B2 (en) | 2000-12-20 | 2004-05-25 | Merck & Co., Inc. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
WO2002094823A1 (en) | 2001-05-24 | 2002-11-28 | Merck Frosst Canada & Co. | 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
JO2311B1 (en) | 2001-08-29 | 2005-09-12 | ميرك فروست كندا ليمتد | Alkyne-aryl phosphodiesterase-4 inhibitors |
WO2003077918A1 (en) | 2002-03-12 | 2003-09-25 | Merck & Co., Inc. | Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
US20060148700A1 (en) * | 2004-11-10 | 2006-07-06 | Daria Mochly-Rosen | Methods and compositions for reducing injury to a transplanted organ |
US8399460B2 (en) | 2009-10-27 | 2013-03-19 | Astrazeneca Ab | Chromenone derivatives |
UY34013A (en) | 2011-04-13 | 2012-11-30 | Astrazeneca Ab | ? CHROMENONE COMPOUNDS WITH ANTI-TUMORAL ACTIVITY ?. |
WO2018058109A1 (en) | 2016-09-26 | 2018-03-29 | Nusirt Sciences, Inc. | Compositions and methods for treating metabolic disorders |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1939738A1 (en) * | 1969-08-05 | 1971-02-18 | Boehringer Mannheim Gmbh | Aminoguanidines and Process for Making Same |
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
DE2935062A1 (en) * | 1978-09-06 | 1980-03-20 | Degussa | SUBSTITUTED AMINOALKYLGUANIDINE, THEIR PRODUCTION AND MEDICINAL PRODUCTS |
DE3929582A1 (en) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE AND THE MEDICINE CONTAINING IT |
DE59302959D1 (en) * | 1992-02-15 | 1996-07-25 | Hoechst Ag | 3,5-Substituted benzoylguanidines, with antiarrhythmic effects and inhibitory effects on cell proliferation |
EP0556673B1 (en) * | 1992-02-15 | 1997-09-17 | Hoechst Aktiengesellschaft | Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as medicaments containing them |
CZ284456B6 (en) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Amino substituted benzylguanidines, process of their preparation and their use for preparing medicaments |
DE59403818D1 (en) * | 1993-02-20 | 1997-10-02 | Hoechst Ag | Substituted benzoylguanidines, processes for their preparation, their use as medicaments, as inhibitors of cellular Na + / H + exchange or as diagnostic agents and medicaments containing them |
DE4318658A1 (en) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them |
DE4318756A1 (en) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them |
-
1993
- 1993-06-05 DE DE4318756A patent/DE4318756A1/en not_active Withdrawn
-
1994
- 1994-05-06 HU HU9401431A patent/HU219452B/en not_active IP Right Cessation
- 1994-05-30 EP EP94108280A patent/EP0628543B1/en not_active Expired - Lifetime
- 1994-05-30 ES ES94108280T patent/ES2134878T3/en not_active Expired - Lifetime
- 1994-05-30 DK DK94108280T patent/DK0628543T3/en active
- 1994-05-30 AT AT94108280T patent/ATE181322T1/en not_active IP Right Cessation
- 1994-05-30 DE DE59408409T patent/DE59408409D1/en not_active Expired - Lifetime
- 1994-06-02 FI FI942599A patent/FI942599A/en unknown
- 1994-06-03 CA CA002125104A patent/CA2125104C/en not_active Expired - Fee Related
- 1994-06-03 IL IL109887A patent/IL109887A/en not_active IP Right Cessation
- 1994-06-03 AU AU64544/94A patent/AU674744B2/en not_active Ceased
- 1994-06-03 NO NO942063A patent/NO302361B1/en not_active IP Right Cessation
- 1994-06-03 NZ NZ260681A patent/NZ260681A/en unknown
- 1994-06-03 JP JP12161694A patent/JP3563106B2/en not_active Expired - Fee Related
- 1994-06-03 ZA ZA943895A patent/ZA943895B/en unknown
- 1994-06-03 CN CN94106321A patent/CN1068308C/en not_active Expired - Fee Related
-
1995
- 1995-06-02 US US08/459,966 patent/US5679712A/en not_active Expired - Lifetime
-
1997
- 1997-06-30 US US08/886,037 patent/US5849775A/en not_active Expired - Lifetime
-
1999
- 1999-08-31 GR GR990402193T patent/GR3031111T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
US5849775A (en) | 1998-12-15 |
US5679712A (en) | 1997-10-21 |
IL109887A (en) | 1998-02-22 |
CN1068308C (en) | 2001-07-11 |
AU674744B2 (en) | 1997-01-09 |
JPH06345715A (en) | 1994-12-20 |
NO942063D0 (en) | 1994-06-03 |
AU6454494A (en) | 1994-12-08 |
ZA943895B (en) | 1995-02-21 |
HUT70554A (en) | 1995-10-30 |
GR3031111T3 (en) | 1999-12-31 |
CN1097737A (en) | 1995-01-25 |
DE59408409D1 (en) | 1999-07-22 |
JP3563106B2 (en) | 2004-09-08 |
CA2125104C (en) | 2006-03-28 |
NZ260681A (en) | 1996-02-27 |
IL109887A0 (en) | 1994-10-07 |
ATE181322T1 (en) | 1999-07-15 |
FI942599A0 (en) | 1994-06-02 |
EP0628543B1 (en) | 1999-06-16 |
DK0628543T3 (en) | 1999-11-22 |
DE4318756A1 (en) | 1994-12-08 |
EP0628543A1 (en) | 1994-12-14 |
NO302361B1 (en) | 1998-02-23 |
NO942063L (en) | 1994-12-06 |
FI942599A (en) | 1994-12-06 |
CA2125104A1 (en) | 1994-12-06 |
HU9401431D0 (en) | 1994-08-29 |
HU219452B (en) | 2001-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2134878T3 (en) | SUBSTITUTED BENZOILGUANIDINES, PROCEDURE FOR ITS PREPARATION, ITS USE AS A MEDICATION OR DIAGNOSTIC AGENT, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM. | |
ES2112453T3 (en) | SUBSTITUTED BENZOILGUANIDINES, PROCEDURE FOR ITS PREPARATION, ITS USE AS A MEDICATION OR DIAGNOSTIC AGENT, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM. | |
ES2135514T3 (en) | ORTO-SUBSTITUTED BENZOILGUANIDINES, PROCEDURE FOR ITS PREPARATION, ITS USE AS A MEDICATION OR DIAGNOSTIC AGENT, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM. | |
ATE146170T1 (en) | SUBSTITUTED BENZOYLGUANIDINES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE OR DIAGNOSTIC AND THE MEDICINAL CONTAINING THEM | |
DE59306029D1 (en) | 3,5-substituted aminobenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them | |
FI935577A (en) | Substituted benzoylamidines, processes for their preparation, their use as pharmaceuticals or diagnostic agents and drugs containing them | |
ES2109545T3 (en) | SUBSTITUTED BENZOYLGUANIDINE, PROCEDURE FOR ITS PREPARATION, ITS USE AS A MEDICINAL PRODUCT OR DIAGNOSTIC AGENT AS WELL AS THE MEDICINAL PRODUCT CONTAINING IT. | |
ZA946074B (en) | Urea-substituted benzoylguanidines process for their preparation their use as pharmaceutical or diagnostic and pharmaceutical containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 628543 Country of ref document: ES |